Direct to Consumer Advertising

1068 WordsFeb 25, 20145 Pages
Business Ethics Second Paper – Deontological Analysis June 19, 2013 Direct-to-Consumer Drug Advertising: Ethical or Not? The United States and New Zealand are the only developed countries that allow direct-to-consumer advertising. Whether the practice of direct to consumer advertising is beneficial to the consumers or not is a highly debated subject with both positions presenting sound reasoning for their position. Whether the practice is beneficial or not to the consumer is not the question, but rather, is advertising prescription drugs directly to consumers ethical? To analyze this question I will use Rawls’s second principle of distributive justice for analysis. (2) use that method, developing the argument in support…show more content…
In regards to the price of prescription drugs, supporters note that the advertising promotes competition among the drug companies, thus driving the drug prices down. Assuming that this is true, which is disputable in itself, “some opponents also suggest that DTCPA increases health care costs because visits to the physician prompted by a drug ad can be a waste of time and money”.(nih.gov) So if the prices are driven down then that would be of benefit to some and if they are, in fact, increased that would be of impact to all consumers. This ethical analysis does not require an answer as to which point of view is true. For this ethical analysis, the questions are if direct-to-consumer drug advertising is “reasonably expected to be to everyone’s advantage” and are the advantages “attached to positions and offices open to all?” (DeGeorge 78) So the drug companies are making more money and insured Americans are obtaining better health, but what about the least advantaged group? What benefit does drug advertising serve to someone that is uninsured and unable to pay for the drug? Has Rawls requirement of the acceptable inequality been met? Acceptable inequality is
Open Document